4-(4-(bis(2-chloroethyl)amino)phenyl)butanoic acid-D8; 4-[Bis(2-chloroethyl)amino]benzenebutanoic Acid-d8; 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric Acid-d8; 4-[Bis(2-chloroethyl)amino]benzenebutanoic Acid-d8; 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric Acid-d8; Ambochlorin-d8; Amboclorin-d8; CB 1348-d8; Chlorambucil-d8; Chloraminophene-d8; Chlorbutin-d8; Chlorobutine-d8; Ecloril-d8; Leukeran-d8; Leukeran Tablets-d8; Linfolizin-d8; Linfolysin-d8; Lympholysin-d8; NCI 3088-d8; NSC 3088-d8; ?-[p-Bis(2-chloroethyl)aminophenyl]butyric Acid-d8; ?-[p-Di(2-chloroethyl)aminophenyl]butyric Acid-d8
Chlorambucil-d8 is a fully characterized chemical compound used as a reference standard of API Chlorambucil. The standard offered is compliant with regulatory guidelines. Chlorambucil-d8 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 305-03-3 (non-labelled)
